Philips collaborates with Ayala HealthCare to provide better community healthcare
Manila, Philippines, Royal Philips(NYSE: PHG, AEX: PHIA) – Recently, Philips Philippines signed a Memorandum of Understanding with Ayala Healthcare Holdings Inc. (AC Health) to roll out an integrated solution that intends to provide better quality healthcare services to the community.
In line with Philips’ aim of improving the lives of three billion people a year by 2025, this strategic collaboration will include the expansion of primary care and other specialty clinics with a total solution proposition, ie: the provision of medical devices, clinical workflow design, software and solutions.
Philips will also be assisting AC Health with necessary training of medical residents and professionals, incorporating Philips’ cutting-edge health technology solutions such as the Lumify ultrasound solution and the sleep and respiratory care solutions.
With the healthcare challenges that the world is facing world today: an aging population, the rise of chronic diseases and resource constraints;
the healthcare industry needs to make a shift away from merely developing individual healthcare products to building truly integrated solutions. These solutions will provide clinicians with more effective ways to diagnose, treat and manage patients by combining hardware, software and services with actionable insights from data and analytics
Country Manager, Philips Philippines Inc.
The partnership with Philips Philippines brings to life our vision of improving the quality of healthcare for Filipinos. It provides an ideal platform for us to engage with our community to deliver innovative solutions that are not only meaningful but also locally relevant
Chief Executive Officer, Ayala Healthcare Holdings Inc.
This collaboration with AC Health is the latest in meaningful collaborations that Philips is undertaking with the aim of providing seamless healthcare experiences through integrated and advanced health technology solutions.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.